{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:59:52Z","timestamp":1773982792635,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.carrev.2025.08.012","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T07:21:10Z","timestamp":1755242470000},"page":"90-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The HighLife transcatheter mitral valve replacement system: A novel two-component platform"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6121-2479","authenticated-orcid":false,"given":"Michail","family":"Penteris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7756-381X","authenticated-orcid":false,"given":"Konstantinos","family":"Lampropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2025.08.012_bb0005","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.119.043391","article-title":"Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990\u20132017","volume":"141","author":"Yadgir","year":"2020","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.carrev.2025.08.012_bb0010","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1016\/j.jacc.2021.04.051","article-title":"Current status and future prospects of transcatheter mitral valve replacement: JACC state-of-the-art review","volume":"77","author":"Alperi","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.carrev.2025.08.012_bb0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/heartjnl-2024-324790","article-title":"Mortality associated with moderate and severe mitral regurgitation in 608 570 men and women undergoing echocardiography","volume":"111","author":"Playford","year":"2025","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2025.08.012_bb0020","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/eurheartj\/ehm001","article-title":"Characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery","volume":"28","author":"Mirabel","year":"2007","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.carrev.2025.08.012_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2010.09.023","article-title":"Percutaneous transcatheter mitral valve repair: a classification of the technology","volume":"4","author":"Chiam","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"10.1016\/j.carrev.2025.08.012_bb0030","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.jacc.2014.08.049","article-title":"The evolution of percutaneous mitral valve repair therapy: lessons learned and implications for patient selection","volume":"64","author":"Beigel","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2025.08.012_bb0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcin.2020.12.038","article-title":"Transcatheter mitral valve replacement: an update on current techniques, technologies, and future directions","volume":"14","author":"Hensey","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"Y","key":"10.1016\/j.carrev.2025.08.012_bb0040","doi-asserted-by":"crossref","first-page":"Y81","DOI":"10.4244\/EIJV12SYA22","article-title":"Highlife transcatheter mitral valve replacement","volume":"12","author":"Lange","year":"2016","journal-title":"EuroIntervention"},{"issue":"23","key":"10.1016\/j.carrev.2025.08.012_bb0045","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1016\/j.jcin.2023.09.003","article-title":"1-year outcomes following transfemoral transseptal transcatheter mitral valve replacement: the highlife TSMVR feasibility study","volume":"16","author":"Schneider","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.08.012_bb0050","author":"HighLife Medical"},{"issue":"16","key":"10.1016\/j.carrev.2025.08.012_bb0055","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.jcin.2017.06.046","article-title":"Transcatheter mitral valve implantation using the HighLife system","volume":"10","author":"Barbanti","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.08.012_bb0060","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1161\/CIRCULATIONAHA.114.012525","article-title":"Outcomes after transapical or transfemoral transcatheter aortic valve replacement: PARTNER-I substudy","volume":"131","author":"Blackstone","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2025.08.012_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcin.2021.10.018","article-title":"Thirty-day outcomes after transfemoral transcatheter mitral valve replacement: results from the intrepid early feasibility study","volume":"15","author":"Zahr","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.08.012_bb0070","series-title":"HIGHLIFE transseptal mitral valve replacement (TSMVR): step by step","author":"Rottbauer","year":"2021"},{"key":"10.1016\/j.carrev.2025.08.012_bb0075","unstructured":"HighLife Medical. \u201cAn Overview of the Innovative HighLife TSMVR Solution\u201d. Available at: https:\/\/www.highlifemedical.com\/our-tsmvr-solution\/. Accessed July 3, 2025."},{"issue":"18_Supplement","key":"10.1016\/j.carrev.2025.08.012_bb0080","doi-asserted-by":"crossref","first-page":"B401","DOI":"10.1016\/j.jacc.2024.09.1130","article-title":"TCT-943 durable valve prosthesis performance and sustained symptom relief: 2-year outcomes following transseptal transcatheter mitral valve replacement in the HighLife TSMVR feasibility study","volume":"84","author":"Ke\u00dfler","year":"2024","journal-title":"JACC"},{"key":"10.1016\/j.carrev.2025.08.012_bb0085","unstructured":"Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04029363. Accessed July 3, 2025."},{"key":"10.1016\/j.carrev.2025.08.012_bb0090","series-title":"Paper presented at: EuroPCR","article-title":"HighLife feasibility study - 52 consecutive patients","author":"Worthley","year":"2023"},{"key":"10.1016\/j.carrev.2025.08.012_bb0095","author":"HighLife Medical"},{"issue":"23","key":"10.1016\/j.carrev.2025.08.012_bb0100","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1016\/j.jcin.2023.10.047","article-title":"HighLife Transfemoral mitral replacement system: promises and uncertainties","volume":"16","author":"Karam","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.08.012_bb0105","author":"HighLife Medical"},{"key":"10.1016\/j.carrev.2025.08.012_bb0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.carrev.2025.06.034","article-title":"The SAPIEN M3 system for transcatheter mitral valve replacement: a new era begins","volume":"79","author":"Penteris","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"issue":"5","key":"10.1016\/j.carrev.2025.08.012_bb0115","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jcin.2024.01.009","article-title":"Left ventricular outflow tract obstruction after Transseptal mitral valve replacement: does HighLife clarity solve it?","volume":"17","author":"Ke\u00dfler","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"issue":"18_Supplement","key":"10.1016\/j.carrev.2025.08.012_bb0120","doi-asserted-by":"crossref","first-page":"B401","DOI":"10.1016\/j.jacc.2024.09.1128","article-title":"TCT-941 addressing anatomic challenges to transcatheter mitral valve replacement with the transseptal HighLife TMVR system","volume":"84","author":"Waggoner","year":"2024","journal-title":"JACC"},{"key":"10.1016\/j.carrev.2025.08.012_bb0125","unstructured":"HighFLO Study - HighLife Trans-septal Mitral Valve Replacement (TSMVR) Feasibility Study of the Open Cell CLARITY Valve (HighFLO). Available from: https:\/\/clinicaltrials.gov\/study\/NCT04888247. Accessed July 8, 2025."},{"issue":"23","key":"10.1016\/j.carrev.2025.08.012_bb0130","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.jcin.2019.07.055","article-title":"Thrombotic risk and antithrombotic strategies after transcatheter mitral valve replacement","volume":"12","author":"Pagnesi","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"19","key":"10.1016\/j.carrev.2025.08.012_bb0135","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.jacc.2021.08.062","article-title":"Transcatheter mitral valve replacement: a need for better patient selection","volume":"78","author":"Rod\u00e9s-Cabau","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2025.08.012_bb0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcin.2021.10.018","article-title":"30-day outcomes following transfemoral transseptal transcatheter mitral valve replacement: intrepid TMVR early feasibility study results","volume":"15","author":"Zahr","year":"2022","journal-title":"J Am Coll Cardiol Intv"},{"issue":"20","key":"10.1016\/j.carrev.2025.08.012_bb0145","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.jcin.2020.06.040","article-title":"Transcatheter mitral valve replacement with the transseptal EVOQUE system","volume":"13","author":"Webb","year":"2020","journal-title":"J Am Coll Cardiol Intv"},{"issue":"13_Supplement","key":"10.1016\/j.carrev.2025.08.012_bb0150","doi-asserted-by":"crossref","first-page":"B8","DOI":"10.1016\/j.jacc.2019.08.030","article-title":"TCT-8 updated 30-day outcomes for the U.S. early feasibility study of the SAPIEN M3 transcatheter mitral valve replacement system","volume":"74","author":"Makkar","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4_Supplement","key":"10.1016\/j.carrev.2025.08.012_bb0155","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.jcin.2025.01.379","article-title":"700.01 the AltaValve early feasibility study: 6-month outcomes following implantation of supra-annular TMVR","volume":"18","author":"Genereux","year":"2025","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.carrev.2025.08.012_bb0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.carrev.2025.06.008","article-title":"The altavalve system for transcatheter mitral valve replacement: a narrative review of early safety and efficacy data","volume":"79","author":"Penteris","year":"2025","journal-title":"Cardiovasc. Revasc. Med."},{"issue":"3","key":"10.1016\/j.carrev.2025.08.012_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.shj.2024.100294","article-title":"AltaValve atrial fixation system for the treatment of severe mitral regurgitation and mitral annular calcification","volume":"8","author":"G\u00e9n\u00e9reux","year":"2024","journal-title":"Struct. Heart"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925004166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925004166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:15:40Z","timestamp":1771499740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925004166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":33,"alternative-id":["S1553838925004166"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.08.012","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The HighLife transcatheter mitral valve replacement system: A novel two-component platform","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}